FIG 4.
Sequence results for TAF and TDF patients who qualified for resistance analysis through week 96. Sequencing results for patients who qualified for sequencing during resistance surveillance through week 96 in the TAF (A) or TDF (B) are shown. The results are presented as amino acid changes from baseline. The number of patients in each analysis is noted as a percentage of the patients in the corresponding treatment group (n, %).